Home  /  Narcotic Drugs and Psychotropic Substances Act, 1985  /  Section 80

Section 80: Application of the Drugs and Cosmetics Act, 1940 not barred

Narcotic Drugs and Psychotropic Substances Act, 1985 • Official Statutory Text & Practice Guide

Statutory Regulation
Legal Standard
Competent Court / Tribunal
Act 1985
Section 79 All 83 Sections of Narcotic Drugs and Psychotropic Substances Act, 1985 Section 81

Legal Commentary & Landmark Judgments: Section 80

Section 80 of the Narcotic Drugs and Psychotropic Substances Act, 1985 establishes an overarching statutory coexistence rule declaring that the provisions of the Act shall be in addition to, and not in derogation of, the Drugs and Cosmetics Act, 1940 (Act 23 of 1940) or any other law for the time being in force. Providing the statutory foundation for dual regulatory control over pharmaceutical substances that possess both medical utility and psychoactive potential, Section 80 ensures that compliance with licensing under the Drugs and Cosmetics Act does not automatically grant immunity from NDPS Act scrutiny, while concurrently ensuring that legitimate pharmaceutical commerce is not paralyzed by overzealous penal prosecution.

  • Cumulative and Non-Derogative Operation: Section 80 mandates that the provisions of the NDPS Act operate 'in addition to, and not in derogation of, the Drugs and Cosmetics Act, 1940 (23 of 1940) or any other law for the time being in force.' This prevents an accused from claiming that the enactment of the NDPS Act repealed the Drugs and Cosmetics Act or that compliance with one statute ousts the application of the other.
  • Dual Regulatory Nexus for Controlled Pharmaceuticals: Substances such as codeine-based syrups, tramadol, buprenorphine, alprazolam, and ketamine are simultaneously 'drugs' under the 1940 Act and 'narcotic drugs' or 'psychotropic substances' under the NDPS Act. Section 80 establishes that a pharmaceutical manufacturer or chemist must satisfy the requirements of both statutory frameworks—holding valid manufacturing/distribution licenses under the 1940 Act and complying with transport and storage quotas under the NDPS Rules.
  • Statutory Boundary Between Regulatory Defect and Trafficking: The critical judicial issue under Section 80 is distinguishing between technical regulatory violations (e.g., improper batch labeling or missing sales registers under the Drugs and Cosmetics Act) and illicit drug trafficking under the NDPS Act. Mere clerical licensing non-compliance cannot automatically be converted into a commercial trafficking offence under Section 21/22 NDPS Act absent proof of intentional illicit diversion.
Key Landmark Precedents:
  • State of Punjab v. Rakesh Kumar (2019) 2 SCC 703: The Supreme Court held that the mere fact that a substance (such as manufactured pharmaceutical drugs containing narcotic substances) is regulated by the Drugs and Cosmetics Act does not exclude the operation of the NDPS Act; trafficking in scheduled formulations without lawful authorization attracts severe NDPS penalties.
  • Hira Singh v. Union of India (2020) 20 SCC 782 (3-Judge Bench): The Supreme Court settled that in a mixture or formulation of a narcotic drug or psychotropic substance with neutral substances, the total weight of the entire mixture/formulation and not merely the pure drug content must be considered to determine small or commercial quantity under the NDPS Act.
  • Medicamen Biotech Ltd. v. Rubina Bose (2008) 7 SCC 196: The Supreme Court examined the interface of pharmaceutical regulatory laws, emphasizing that where statutory procedures require sampling and independent testing, strict compliance is essential to sustain criminal liability.
Courtroom Practice & Strategic Litigation Guidance:

In defending licensed chemists, pharmaceutical stockists, and doctors charged under the NDPS Act for possessing commercial stocks of codeine syrup, alprazolam, or tramadol: Present wholesale purchase invoices, batch manufacturing licenses, Form 20/21 retail drug licenses, and stock registers maintained under the Drugs and Cosmetics Act. Cite Section 80 to argue that possession is covered by a legitimate statutory license and that any bookkeeping discrepancy constitutes a technical regulatory breach under the 1940 Act rather than an illicit trafficking conspiracy under Section 21/22 NDPS Act.

Section 79 All 83 Sections of Narcotic Drugs and Psychotropic Substances Act, 1985 Section 81